Magnetic responsive hydrogel optical fiber and preparation method and application thereof

The magnetically responsive hydrogel optical fiber with a three-layer structure design solves the problems of magnetic particle scattering and cross-interference, achieving efficient light transmission and stable magnetic drive, and is suitable for photothermal therapy of deep tissue cancer.

CN122424115APending Publication Date: 2026-07-21DONGHUA UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610751381.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-05-28
Publication Date
2026-07-21

Smart Images

  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
  • Figure SMS_4
    Figure SMS_4
Patent Text Reader

Abstract

The application discloses a kind of magnetically responsive hydrogel optical fiber and its preparation and application, belong to medical biomaterial field.The optical fiber includes from inside to outside: polyethylene glycol diacrylate and acrylamide photocrosslinking light transmission core layer;Calcium alginate low refractive index skin layer;Doped nano-magnetic response layer of ferriferrous oxide;And polydopamine grafting polyvinylpyrrolidone lubricating layer.It is prepared by coaxial extrusion and light / calcium step-by-step crosslinking.The structure realizes the spatial isolation and anti-interference of light transmission and magnetic drive, has low background light loss and anti-bending stability, has biomechanics matching, ultra-low friction and magnetic field accurate active navigation ability, solves the pain point that extremely soft optical fiber is difficult to directional intervention.Suitable for deep tissue precise photothermal therapy, in vivo continuous optical sensing and minimally invasive diagnosis and treatment integration and other frontier medical fields.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of medical biomaterials, specifically to a magnetically responsive hydrogel optical fiber and its preparation method, as well as the application of the optical fiber in the preparation of a photothermal therapy device for deep tissue cancer. Background Technology

[0002] In recent years, flexible optical electronic devices, especially hydrogel-based optical fibers, have shown great potential in bio-integrated electronics, implantable devices, and soft robotics due to their excellent biocompatibility and mechanical properties similar to biological tissues. Magnetically controlled actuation, with its advantages of non-contact operation, strong penetration, high precision, and good safety, has become one of the ideal methods for manipulating soft devices. However, existing magnetically controlled hydrogel devices typically mix or integrate magnetic functional units with optical / sensing functional units in the same area, leading to many unavoidable problems. 1. Magnetic particles typically have strong light scattering and absorption properties, which severely degrade the light transmission efficiency in gels, limit the range of transmittable light wavelengths, and reduce the signal-to-noise ratio, greatly limiting their application as high-efficiency light guides.

[0003] 2. The magnetic and optical components are not spatially isolated, resulting in cross-interference: local stress and non-uniform deformation caused by the external magnetic field will seriously damage the stability of the internal optical path, and the introduction of a large amount of optical matrix material will inevitably weaken the overall magnetic response performance.

[0004] 3. Traditional blending designs result in mutual constraints between optical and magnetic properties, making it difficult to independently optimize component ratios and structures, thus limiting design freedom.

[0005] To overcome the material limitations of existing hybrid hydrogel optical fibers that struggle to achieve both high-precision light guiding and stable magnetic drive, this invention proposes a hydrogel optical fiber that effectively isolates the light transmission path from the magnetic response layer in both space and function, while also providing anti-crosstalk. Summary of the Invention

[0006] To address the aforementioned technical problems, this invention provides a method for preparing a magnetically responsive hydrogel optical fiber for photothermal therapy of deep tissue cancer, thereby solving the problems of low precision and insufficient flexibility of existing hydrogel optical fibers.

[0007] To achieve the above objectives, the present invention provides a magnetically responsive hydrogel optical fiber and a method for preparing the same, comprising the following steps: (1) Preparation of optical fiber core matrix solution Polyethylene glycol diacrylate, acrylamide and photoinitiator were added to water and mixed to obtain an optical fiber core matrix solution; (2) Preparation of optical fiber skin matrix solution Sodium alginate was added to water and mixed well to obtain an optical fiber skin matrix solution; (3) Prepare the matrix solution for the outermost magnetic response layer Magnetic particles, sodium alginate and dispersant polyethylene glycol are added to water and mixed. The magnetic particles are then dispersed uniformly by ultrasound to obtain a magnetic response layer matrix solution. (4) Simultaneous extrusion and overall crosslinking The optical fiber core matrix solution and optical fiber sheath matrix solution prepared in steps (1) and (2) are simultaneously extruded into a coagulation bath (calcium chloride solution) using a coaxial circular needle and the photoinitiator is initiated to crosslink, so as to form a complete hydrogel optical fiber structure. (5) Magnetic response layer coating The hydrogel optical fiber formed in step (4) is immersed in the magnetic response layer matrix solution prepared in step (3) and left to stand for a period of time before being slowly pulled out and finally placed in a coagulation bath (calcium chloride solution) to form a magnetic response layer. (6) Surface lubrication treatment The hydrogel magnetic response fiber formed in step (5) is immersed in dopamine hydrochloride solution, cleaned and then immersed in polyvinylpyrrolidone solution. It is then taken out and rinsed thoroughly with deionized water to remove ungrafted polyvinylpyrrolidone, and finally a dual-core magnetic control optical fiber is obtained.

[0008] In the design of the material system, this invention follows the principle of a three-in-one approach: "optical properties - mechanical matching - biological function". 1. Core layer is a PEGDA / AAM interpenetrating network: (a) High transmittance and refractive index control: Acrylamide (AAM) is selected to provide high water content and high transparency as the main body for light transmission; polyethylene glycol diacrylate (PEGDA, Mw=700) is introduced as a crosslinking agent, which not only adjusts the refractive index of the core layer to be slightly higher than that of the skin layer (satisfying the total internal reflection condition n) core >n cladding (a) Chemical cross-linking enhances the elastic modulus of the hydrogel, preventing optical fiber breakage during long-distance transmission. (b) Low scattering loss: The AAM / PEGDA system has a uniform texture after polymerization and extremely low Rayleigh scattering loss, making it suitable for deep transmission of long wavelengths (near-infrared light).

[0009] 2. The outer layer is calcium alginate: (a) Low refractive index cladding: Sodium alginate hydrogel has extremely high water content (>98%), and its refractive index is close to that of pure water (approximately 1.33), lower than that of the core layer, effectively limiting light escape during transmission. (b) Rapid prototyping and blocking: Utilizing the reaction of sodium alginate with Ca²⁺ + The instantaneous gelation property rapidly forms an "exoskeleton" during coaxial spinning, protecting the incompletely cured core layer and ensuring its circular cross-section.

[0010] 3. The magnetic response layer is composed of magnetic particles / sodium alginate / PEG: (a) Spatial isolation and anti-crosstalk design: Nano-iron oxide (Fe3O4) with high saturation magnetization is selected as the magnetron sputtering medium and strictly confined to the outermost layer of the optical fiber. This physical layered structure constructs an effective spatial isolation barrier, completely avoiding interference from high light absorption and high scattering magnetic particles on the central optical path transmission, and ensuring the simultaneous realization of strong magnetic driving force and low-loss light transmission performance.

[0011] (b) Structural uniformity and stable response: PEG is introduced as a macromolecular dispersant. The steric hindrance effect generated by its chain segment conformation prevents the aggregation of nano Fe3O4 during the crosslinking process, ensuring a highly uniform distribution of magnetic particles in the gel network. This avoids navigation jitter and local stress concentration defects caused by uneven distribution of local magnetic moments.

[0012] 4. Surface coating is PDA / PVP: Interface anchoring and super lubrication: The strong adhesion of polydopamine is used as an intermediate layer to solve the problem of difficult grafting on the surface of inert hydrogel; then polyvinylpyrrolidone is grafted to form a hydration layer in a humid environment, which greatly reduces the frictional resistance of optical fibers when they shuttle through biological tissues (such as blood vessels and muscle gaps) and prevents optical fibers from failing due to buckling.

[0013] As a further preferred embodiment of the present invention, the photoinitiator is 2-hydroxy-2-methyl-1-[4-(2-hydroxyethoxy)phenyl]-1-propanone (I2959); the coagulation bath is an aqueous solution of calcium chloride with a mass percentage concentration of 1-5%, for example, its mass percentage concentration can be 0.5%, 1%, 2%, 3%, 4% or 5%, etc., which are typical but non-limiting mass percentage contents.

[0014] As a further preferred embodiment of the present invention, in the optical fiber core matrix solution, the content of acrylamide is 20-40 wt.%, the content of polyethylene glycol diacrylate is 2-8 wt.%, and the content of photoinitiator is 0.5-2 wt.%. For example, the acrylamide content can be typical but not limiting, such as 20 wt.%, 25 wt.%, 30 wt.%, 35 wt.%, 40 wt.%, etc.; the polyethylene glycol diacrylate content can be typical but not limiting, such as 2 wt.%, 3 wt.%, 4 wt.%, 5 wt.%, 6 wt.%, 7 wt.%, 8 wt.%, etc.; and the photoinitiator content can be typical but not limiting, such as 0.5 wt.%, 1 wt.%, 15 wt.%, 2 wt.%.

[0015] As a further preferred embodiment of the present invention, the content of sodium alginate in the optical fiber sheath matrix solution is 0.5~2 wt.%. For example, the content of sodium alginate can be a typical but non-limiting mass percentage such as 0.5 wt.%, 1 wt.%, 1.5 wt.%, 2 wt.%.

[0016] As a further preferred embodiment of the present invention, the outermost magnetic response layer matrix solution contains sodium alginate at a content of 0.5-2 wt.%, nano-ferric oxide at a content of 20-50 wt.%, and PEG at a content of 1-3 wt.%. For example, sodium alginate can be at typical but non-limiting mass percentages such as 0.5 wt.%, 1 wt.%, 1.5 wt.%, and 2 wt.%, nano-ferric oxide at a content of 20 wt.%, 30 wt.%, 40 wt.%, and 50 wt.%, and PEG at a content of 1 wt.%, 1.5 wt.%, 2 wt.%, 2.5 wt.%, and 3 wt.%.

[0017] As a further preferred embodiment of the present invention, the content of CaCl2 in the coagulation bath is 1~5 wt.%, for example, the content of CaCl2 can be a typical but non-limiting mass percentage concentration such as 1 wt.%, 1.5 wt.%, 2 wt.%, 3 wt.%, 4 wt.%.

[0018] As a further preferred embodiment of the present invention, in the surface lubrication treatment step, the dopamine hydrochloride solution is a dopamine hydrochloride solution with a concentration of 1~3 mg / mL prepared using 10 mM Tris-HCl buffer as a solvent; the content of the polyvinylpyrrolidone (PVP) aqueous solution is 5~10 wt.%. For example, the concentration of the dopamine hydrochloride solution can be a typical but non-limiting mass percentage such as 1 mg / mL, 1.5 mg / mL, 2 mg / mL, 2.5 mg / mL, 3 mg / mL, etc., and the content of the polyvinylpyrrolidone (PVP) aqueous solution can be a typical but non-limiting mass percentage such as 5 wt.%, 6 wt.%, 7 wt.%, 8 wt.%, 9 wt.%, 10 wt.%.

[0019] According to a second aspect of the present invention, the present invention also provides a magnetically responsive hydrogel optical fiber, which is prepared by the above-described method.

[0020] According to a third aspect of the present invention, the present invention also provides the application of magnetically responsive hydrogel optical fibers in the preparation of photothermal therapy devices for deep tissue cancer.

[0021] Compared with the prior art, the present invention can achieve the following beneficial effects: (1) Active navigation and control: This technology achieves a leap from "passive deformation" to "magnetic field-driven active navigation," solving the problem of precise orientation and deep implantation of ultra-soft optical fibers in complex tissue gaps. The main driving mechanism is based on the interaction between the magnetic layer and the external gradient magnetic field. Since the Fe3O4 nanoparticles are physically anchored in the outermost calcium alginate gel network, when the optical fiber is placed in the external gradient magnetic field, the magnetic particles are magnetized to generate a magnetic dipole moment. This magnetic dipole moment interacts with the external magnetic field to generate a magnetic torque, which preferentially acts on the free end of the optical fiber, thereby achieving directional bending and navigation of the optical fiber tip. Since the magnetic layer and the optical core are physically isolated in space, the deformation stress generated by the driving is mainly concentrated in the skin layer, minimizing the impact on the optical path of the core layer.

[0022] (2) Dynamic optical modulation: It provides a non-contact optical property control method, which uses magnetic field to induce microstructure recombination to realize instantaneous modulation of local refractive index, scattering coefficient and light intensity.

[0023] (3) Mechanical compatibility and reinforcement: It maintains the low modulus characteristics of bio-matching, while using the "virtual stiffness" provided by magnetic guidance to overcome the mechanical limitations of soft materials that are easy to knot and difficult to control. Detailed Implementation

[0024] The following provides a detailed description of specific embodiments of the present invention. It should be understood that the specific embodiments described herein are for illustrative and explanatory purposes only and are not intended to limit the scope of the invention.

[0025] Unless otherwise defined, the technical terms used in the following embodiments have the same meanings as commonly understood by those skilled in the art to which this invention pertains. Unless otherwise specified, the experimental reagents used in the following embodiments are conventional biochemical reagents; and the experimental methods described are conventional methods.

[0026] Example 1: Coating of coaxial extruded hydrogel optical fiber with magnetic response layer (1) Preparation of optical fiber core matrix solution Using water as a solvent, the remaining components were mixed in the following proportions: 5 wt.% PEGDA (Mw=700 Da), 35 wt.% AAM, and 0.5 wt.% I2959, to prepare an optical fiber core matrix solution.

[0027] (2) Preparation of optical fiber skin matrix solution Using water as a solvent, the remaining components were prepared as a fiber optic sheath matrix solution at a concentration of 2 wt.% sodium alginate.

[0028] (3) Preparation of magnetic response coating substrate solution Using water as a solvent, the remaining components are mixed in the following proportions: 2 wt.% sodium alginate, 20 wt.% nano iron oxide powder, and 2 wt.% PEG6000. The mixture is then sonicated for 1 hour to prepare the optical fiber core matrix solution.

[0029] (4) Preparation of optical hydrogel fibers The optical fiber core-sheath matrix solutions prepared in steps (1) and (2) are simultaneously extruded into a coagulation bath (2 wt.% CaCl2 solution) through a coaxial spinning needle. The flow rates of the sheath and core layers are 150 μL / min and 100 μL / min, respectively. The core layer solution has a low viscosity, while the sheath layer has a high viscosity. The sheath layer solidifies rapidly after contacting calcium ions in the coagulation bath, encapsulating the core layer solution within it. Simultaneously, the fibers extruded into the coagulation bath are crosslinked by irradiation under blue light at a wavelength of 405 nm using photocrosslinking, thereby obtaining optical hydrogel fibers.

[0030] (5) Magnetic response layer coating The optical hydrogel fiber prepared in step (4) is immersed in the magnetic response coating solution prepared in step (3) and slowly pulled out. Finally, it is solidified in a coagulation bath (2 wt.% CaCl2 solution) to obtain a hydrogel magnetic response optical fiber.

[0031] (6) Surface lubrication treatment A 2 mg / mL dopamine hydrochloride solution was prepared using 10 mM Tris-HCl buffer as the solvent. The hydrogel magnetic response fiber formed in step (5) was immersed in the dopamine hydrochloride solution to fully wet it, then washed with deionized water, and then immersed in an 8 wt.% polyvinylpyrrolidone aqueous solution. After being taken out, it was rinsed thoroughly with deionized water to remove the ungrafted polyvinylpyrrolidone, and finally the magnetic response hydrogel optical fiber was obtained.

[0032] The performance tests of the magnetically responsive hydrogel optical fiber prepared in Example 1 are as follows: Test Example 1: 450nm wavelength laser light attenuation coefficient: 0.6 dB / cm; 808nm wavelength laser light attenuation coefficient: 0.24 dB / cm.

[0033] The optical attenuation coefficient was measured using a high-precision photometer at room temperature (25℃) using the cut-off method. The specific steps were as follows: One end of the optical fiber was connected to an 808nm light source via a coupling head, and the other end was connected to the photometer. The output optical power P1 at the initial length L1 was recorded. Keeping the coupling state at the light source end unchanged, a section was cut off from the output end using a blade, and the optical power P2 at the current length L2 was recorded. The optical attenuation coefficient was then calculated using the formula α = - Calculated tensile strength: 1.2 MPa (tensile strength was measured using a universal testing machine with a 20N load cell and a tensile rate of 50 mm / min); coefficient of friction: 0.03 (measured using a rotational rheometer at a pressure of 1.5 kPa and a shear rate of 1.0 s⁻¹). -1 ).

[0034] Test Example 2: Magnetic Response Accuracy and Dynamic Navigation Capability Test To verify the active navigation performance of the magnetically responsive hydrogel optical fiber of the present invention, one end of the optical fiber prepared in Example 1 was fixed, and the free end suspension length was set to 30 mm. Different gradient external magnetic fields (0~100 mT / m) were applied to the fiber tip using an electromagnet array, and the deflection angle and response time of the fiber tip were recorded. The test results showed that: (1) With the increase of the magnetic field gradient, the deflection angle of the fiber tip showed a highly nonlinear and controllable change. Under a magnetic field gradient of 50 mT / m, the deflection angle could reach more than 90°. After the magnetic field was removed, thanks to the excellent elastic recovery ability of the PEGDA / AAM core layer, the optical fiber quickly recovered to the initial straight state within 0.2 s without plastic deformation. (2) The response hysteresis test showed that under an alternating magnetic field of 1 Hz, the fiber tip could achieve a phase delay of less than 50 ms, proving its potential for high-frequency precise navigation in complex vascular networks.

[0035] Test Example 3: Magnetic Response Accuracy and Dynamic Navigation Capability Test Optical transmission stability test under dynamic deformation (force-optical coupling test): Hydrogel optical fibers inevitably undergo bending deformation during deep tissue puncture. The optical fiber (10 cm in length) prepared in Example 1 was connected to an 808 nm near-infrared laser source. Using a straight, unbent optical fiber as a reference, the fiber was bent to different radii of curvature (R = 20 mm, 10 mm, 5 mm, 2 mm), and the light intensity attenuation at the output end was monitored using a photometer. The results are shown in Table 1: Table 1 As shown in Table 1, even at a curvature radius as low as 5 mm (close to an extreme 180° fold), the resulting additional light attenuation is only 0.61 dB / cm. This is attributed to the perfect refractive index step (Δn≈ 0.08) between the cortical sodium alginate and the core polymer, which effectively limits beam escape caused by bending and ensures efficient transmission of laser energy in complex deep tissue pathways.

[0036] Test Example 4: In vitro simulation verification of deep tissue photothermal therapy To verify the practical efficacy of this invention in deep tissue photothermal therapy, an ex vivo pork tissue model was constructed. A light absorber (such as indocyanine green ICG solution, concentration 50 μg / mL) was injected deep into a 3 cm thick pork tissue layer to simulate a tumor lesion. Using magnetic field navigation, the optical fiber prepared in Example 1 was inserted through a puncture site, precisely positioning the fiber tip at the edge of the "tumor" region. An 808 nm near-infrared laser with a power of 1.0 W / cm² was coupled to the fiber input, and continuous irradiation was performed for 5 minutes. Tissue temperature changes were monitored using an infrared thermal imager. Within 3 minutes of laser activation, the temperature of the target area at the fiber tip rapidly increased from 37°C to over 52°C.

[0037] Comparative Example 1 (quartz optical fiber): Commonly available medical-grade quartz optical fiber (core diameter approximately 400 μm) was selected. After removing the original polymer coating from the surface, a magnetic sodium alginate solution was dipped and cross-linked with calcium ions using the same process steps (5) as in Example 1 to prepare a magnetic response coating of uniform thickness on the surface of the hard quartz optical fiber. Then, the surface was lubricated using the same process steps (6).

[0038] The performance tests of the two types of magnetically controlled optical fibers obtained in Comparative Example 1 and Comparative Example 1 are shown in Table 2.

[0039] Table 2 As shown in Table 2, although rigid optical fibers have excellent light transmittance, the losses of this invention are completely acceptable for short-distance in vivo treatment. This invention achieves key capabilities of active navigation and non-invasive intervention through a minor compromise in optical transmission efficiency.

[0040] Comparative Example 2 (fiber without magnetic layer): The optical hydrogel fiber without magnetic layer prepared in step (4) of Example 1 was directly subjected to surface lubrication treatment according to the same process step (6).

[0041] Comparative Example 3 (without sodium alginate skin): In Example 1, the optical fiber skin matrix solution was omitted in step (4). The optical fiber core matrix solution in step (1) was used to form optical hydrogel fibers by extruding the core layer through the core layer hole of a coaxial circular needle. Then, the magnetic response layer coating in step (5) and the surface lubrication treatment in step (6) were carried out in the same way as in Example 1.

[0042] The near-infrared light attenuation coefficient of the optical fibers obtained in Comparative Example 1, Comparative Example 2 and Comparative Example 3 were tested, and the results are shown in Table 3.

[0043] Table 3 Compared to Comparative Example 2, the light loss increased only slightly after coating with the magnetic layer (approximately 0.03 dB / cm), but significantly decreased compared to Comparative Example 3. This confirms that the sodium alginate skin layer can effectively confine the light field within the core layer, preventing the interaction between light and the outer layer of light-absorbing iron oxide particles.

[0044] Comparative Example 4 (fiber without lubrication layer): This is the fiber with a magnetic layer but without PDA / PVP surface treatment prepared in step (5) of Example 1.

[0045] Table 4 The untreated magnetic hydrogel in Comparative Example 4 had a rough and sticky surface, and numerous experiments showed that it was difficult to slide in dense tissues, making it unsuitable for photothermal therapy of deep tissue cancers. In contrast, the optical fiber in Example 1, after being grafted with PVP, formed a stable hydration layer on its surface. Compared to the optical fiber sample in Comparative Example 4, the coefficient of friction was reduced by an order of magnitude, allowing it to smoothly pass through blood vessels or tissue gaps without buckling in practical applications.

[0046] Example 2 The preparation method was basically the same as that in Example 1. The only difference from Example 1 was the composition ratio of each matrix solution, as follows: In step (1), the optical fiber core matrix solution was 20 wt.% AAM, 2 wt.% PEGDA (Mw=700Da), and 0.5 wt.% I2959; In step (2), the optical fiber skin matrix solution was 0.5 wt.% sodium alginate; In step (3), the magnetic response coating matrix solution was 0.5 wt.% sodium alginate, 50 wt.% nano iron oxide powder, and 1 wt.% PEG6000; In step (4), the coagulation bath was 1 wt.% CaCl2 solution; In step (5), the surface lubrication treatment was 1 mg / mL dopamine hydrochloride solution and 5 wt.% PVP aqueous solution.

[0047] Example 3 The preparation method was basically the same as that in Example 1. The only difference from Example 1 was the composition ratio of each matrix solution, as follows: In step (1), the optical fiber core matrix solution was 40 wt.% AAM, 8 wt.% PEGDA (Mw=700Da), and 1.5 wt.% I2959; In step (2), the optical fiber skin matrix solution was 1.5 wt.% sodium alginate; In step (3), the magnetic response coating matrix solution was 1.5 wt.% sodium alginate, 35 wt.% nano iron oxide powder, and 3 wt.% PEG6000; In step (4), the coagulation bath was 4 wt.% CaCl2 solution; In step (5), the surface lubrication treatment was 3 mg / mL dopamine hydrochloride solution and 10 wt.% PVP aqueous solution.

[0048] Example 4 The preparation method was basically the same as that in Example 1, except that the composition ratio of each matrix solution was different: In step (1), the optical fiber core matrix solution was 30 wt.% AAM, 4 wt.% PEGDA (Mw=700 Da), and 1.0 wt.% I2959; In step (2), the optical fiber skin matrix solution was 1.0 wt.% sodium alginate; In step (3), the magnetic response coating matrix solution was 1.0 wt.% sodium alginate, 40 wt.% nano iron oxide powder, and 2 wt.% PEG6000; In step (4), the coagulation bath was 2 wt.% CaCl2 solution; In step (5), the surface lubrication treatment was 2 mg / mL dopamine hydrochloride solution and 8 wt.% PVP aqueous solution.

[0049] The magnetically responsive hydrogel optical fibers prepared in Examples 2, 3, and 4 were subjected to the same performance characterization as those in Test Examples 1 and 2, and the results are shown in Table 5.

[0050] Table 5 While specific embodiments of the present invention have been described above, those skilled in the art should understand that these are merely illustrative examples, and various changes or modifications can be made to these embodiments without departing from the principles and essence of the present invention. The scope of protection of the present invention is defined only by the appended claims.

Claims

1. A method for preparing a magnetically responsive hydrogel optical fiber, characterized in that, Includes the following steps: (1) Preparation of optical fiber core matrix solution Polyethylene glycol diacrylate, acrylamide and photoinitiator were added to water and mixed to obtain an optical fiber core matrix solution; (2) Preparation of optical fiber skin matrix solution Sodium alginate was added to water and mixed well to obtain the optical fiber substrate solution; (3) Preparation of magnetic response layer matrix solution Magnetic particles, sodium alginate and dispersant polyethylene glycol are added to water and mixed. The magnetic particles are then dispersed uniformly by ultrasound to obtain a magnetic response layer matrix solution. (4) Preparation of hydrogel optical fibers The optical fiber core matrix solution and optical fiber sheath matrix solution prepared in steps (1) and (2) are simultaneously extruded into a coagulation bath using a coaxial circular needle and the photoinitiator is initiated to crosslink to form a complete hydrogel optical fiber structure, thus obtaining a hydrogel optical fiber. (5) Magnetic response layer coating The hydrogel optical fiber formed in step (4) is immersed in the magnetic response layer matrix solution prepared in step (3) and left to stand for a period of time. Then it is taken out and placed in a coagulation bath to form a magnetic response layer, thus obtaining a hydrogel magnetic response optical fiber. (6) Surface lubrication treatment The hydrogel magnetic response fiber formed in step (5) is immersed in dopamine hydrochloride solution, cleaned and then immersed in polyvinylpyrrolidone aqueous solution. It is then taken out and rinsed thoroughly with deionized water to remove ungrafted polyvinylpyrrolidone, and finally magnetic response hydrogel optical fiber is obtained. The coagulation bath is a calcium chloride solution.

2. The method for preparing magnetically responsive hydrogel optical fibers according to claim 1, characterized in that, The optical fiber core matrix solution contains 20-40 wt.% acrylamide (AAM) and 2-8 wt.% polyethylene glycol diacrylate; the average molecular weight of polyethylene glycol methylpropionate is 700.

3. The method for preparing magnetically responsive hydrogel optical fibers according to claim 1, characterized in that, The photoinitiator is 2-hydroxy-2-methyl-1-[4-(2-hydroxyethoxy)phenyl]-1-propanone.

4. The method for preparing magnetically responsive hydrogel optical fibers according to claim 1, characterized in that, The sodium alginate content in the optical fiber skin matrix solution is 0.5~2 wt.%.

5. The method for preparing magnetically responsive hydrogel optical fibers according to claim 1, characterized in that, The magnetic particles are nano-iron oxide (Fe3O4) and the dispersant is polyethylene glycol with a molecular weight of 6000.

6. The method for preparing magnetically responsive hydrogel optical fibers according to claim 1, characterized in that, The magnetic response layer matrix solution contains 0.5-2 wt.% sodium alginate, 20-50 wt.% magnetron nano-iron oxide powder, and 0.5-3 wt.% polyethylene glycol dispersant.

7. The method for preparing magnetically responsive hydrogel optical fibers according to claim 1, characterized in that, In the surface lubrication treatment step, the dopamine hydrochloride solution is prepared by adding 1~3 mg / mL of dopamine hydrochloride solution to 10 mM Tris-HCl buffer and adjusting the pH to 8~9; the concentration of the polyvinylpyrrolidone aqueous solution is 5~10 wt.%.

8. The method for preparing magnetically responsive hydrogel optical fibers according to claim 1, characterized in that, The concentration of the coagulation bath in steps (4) and (5) is independently selected to be 0.5~5 wt.%.

9. A method for preparing a magnetically responsive hydrogel optical fiber, characterized in that, It is prepared by the method described in any one of claims 1-8.

10. The application of the magnetically responsive hydrogel optical fiber according to claim 9 in the preparation of a photothermal therapy device for deep tissue cancer.